Related Experiment Videos
Relationship between plasminogen activators and stomach carcinoma stage
Y Umehara1, T Kimura, M Yoshida
1First Department of Surgery, Hamamatsu University School of Medicine, Japan.
Acta Oncologica (Stockholm, Sweden)
|January 1, 1991
Summary
Urokinase-type plasminogen activator (u-PA) is elevated in gastric cancer tissue compared to normal tissue. Higher u-PA levels correlate with advanced tumor stage, nodal involvement, and metastasis, indicating its role in gastric cancer progression.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Plasminogen activators (PAs) are crucial enzymes involved in extracellular matrix degradation.
- Tissue-type PA (t-PA) and urokinase-type PA (u-PA) are key isoforms with distinct roles.
- Altered PA levels are implicated in various cancer types, including gastric cancer.
Purpose of the Study:
- To quantify and compare antigen levels of t-PA and u-PA in gastric carcinoma and normal gastric mucosa.
- To investigate the correlation between u-PA levels and clinicopathological features of gastric cancer.
Main Methods:
- Measurement of t-PA and u-PA antigen levels in tissue extracts from 30 gastric carcinomas and matched normal mucosa.
- Statistical analysis to compare levels between cancer and normal tissues.
- Correlation analysis between u-PA levels and tumor stage, nodal status, differentiation, and metastasis.
Main Results:
- Significantly higher t-PA levels were observed in normal gastric mucosa compared to cancer tissue.
- Significantly higher u-PA levels were found in gastric cancer tissue versus normal mucosa.
- u-PA levels showed a positive correlation with increasing tumor stage, nodal involvement, poor differentiation, and presence of distant metastasis (liver, peritoneum).
Conclusions:
- u-PA is upregulated in gastric cancer and serves as a potential biomarker for tumor progression.
- Elevated u-PA levels are associated with aggressive clinicopathological features, suggesting its role in invasion and metastasis.
- Further research into u-PA's role could lead to targeted therapeutic strategies for advanced gastric cancer.